Circulating tumor DNA in advanced lung cancers: A prospective evaluation of matched therapy and shedding detection.

Michael Offin,Dennis Stephens,Joshua K. Sabari,Alex Makhnin,Mackenzie Myers,Ai Ni,Nick Pavlakis,Stephen Clarke,Nidhi Tandon,Sutirtha Datta,Lee Lim,Mark Li,Maria E. Arcila,Valerie W. Rusch,David R. Jones,Alexander Drilon,Charles M. Rudin,Andreas Rimner,James M. Isbell,Bob T. Li

Circulating tumor DNA in advanced lung cancers: A prospective evaluation of matched therapy and shedding detection.

2018

e21234Background: Liquid biopsy of circulating tumor DNA (ctDNA) by next generation sequencing (NGS) is widely adopted in clinical practice. ctDNA shedding across different lung cancer histologies,...

Keywords:

Circulating tumor DNA
Pathology
Lung
Medicine
Clinical Practice
Oncology
Liquid biopsy
Internal medicine
DNA sequencing
prospective evaluation
Lung cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations